Peter‐A. Löschmann

Author

Peter‐A. Löschmann

University of Tübingen

Also Known As

Peter-A Löschmann, Peter-A. Löschmann, Peter‐A Löschmann, Peter‐A. Löschmann

Publications

745

Citations

H-Index

Concepts

All Affiliations

University of Tübingen Parkinson's UK King's College Hospital Medizinische Hochschule Hannover National Hospital for Neurology and Neurosurgery

About

Peter‐A. Löschmann is an author at University of Tübingen specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	417
2	Health Sciences	2	2	120
3	Social Sciences	1	1	34
4	Immunology	1	1	26
5	Microbiology	1	1	26

Peter‐A. Löschmann

Publications

737

Citations

H-Index

Page 1

	Year	Citations
Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide Michael T. Heneka, Peter‐A. Löschmann, Marc Gleichmann, Journal of Neurochemistry	1998	199
Cooperative Interception of Neuronal Apoptosis by BCL‐2 and BAG‐1 Expression: Prevention of Caspase Activation and Reduced Production of Reactive Oxygen Species Jörg B. Schulz, Dirk Bremen, John C. Reed, Journal of Neurochemistry	1997	107
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia Jörg B. Schulz, Michael Weller, Russell T. Matthews, Cell Death and Differentiation Cerebral Vascular RegulationMedicineHypoxia (Medicine)Caspase InhibitionCell Death	1998	95
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets Peter‐A. Löschmann, Lance A. Smith, Klaus W. Lange, Psychopharmacology Psychoactive DrugNormal Common MarmosetsMotor ActivityMedicineNeuropharmacology	1991	73
The NMDA antagonist memantine impairs classical eyeblink conditioning in humans Markus M. Schugens, Ralf Egerter, Irene Daum, Neuroscience Letters OptogeneticsOcular DiseaseRetinaOphthalmologyMedicine	1997	66
Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437 Peter‐A. Löschmann, Piang Ngok Chong, Masahiro Nomoto, European Journal of Pharmacology Neurodegenerative DiseasesDermal ApplicationMedicineMptp-induced ParkinsonismExperimental Neuropathology	1989	53
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets Peter‐A. Löschmann, Lance A. Smith, Klaus W. Lange, Psychopharmacology Motor ActivityMedicinePhysiologyNeuropharmacologyMotor Control	1992	47
The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia Angelika Richter, Wolfgang Löscher, Peter‐A. Löschmann European Journal of Pharmacology NeurophysiologyAntidystonic EffectsMedicineNeurotransmitterAnimal Model	1993	34
Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide Michael T. Heneka, Lucia Dumitrescu, Peter‐A. Löschmann, Journal of Chemical Neuroanatomy InflammationInterferon GammaPathogenesisImmunologyBacterial Lipopolysaccharide	2000	26
The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalised dystomia Angelika Richter, Peter‐A. Löschmann, Wolfgang Löscher European Journal of Pharmacology Mutant Hamster ModelMedicineGynecologyCentral Nervous SystemPharmacology	1994	23

Page 1